182 related articles for article (PubMed ID: 27966018)
1. Identification of lead BAY60-7550 analogues as potential inhibitors that utilize the hydrophobic groove in PDE2A: a molecular dynamics simulation study.
Kumar J; Umar T; Kausar T; Mobashir M; Nayeem SM; Hoda N
J Mol Model; 2017 Jan; 23(1):7. PubMed ID: 27966018
[TBL] [Abstract][Full Text] [Related]
2. X-ray crystal structure of phosphodiesterase 2 in complex with a highly selective, nanomolar inhibitor reveals a binding-induced pocket important for selectivity.
Zhu J; Yang Q; Dai D; Huang Q
J Am Chem Soc; 2013 Aug; 135(32):11708-11. PubMed ID: 23899287
[TBL] [Abstract][Full Text] [Related]
3. Determination of the structure of human phosphodiesterase-2 in a bound state and its binding with inhibitors by molecular modeling, docking, and dynamics simulation.
Hamza A; Zhan CG
J Phys Chem B; 2009 Mar; 113(9):2896-908. PubMed ID: 19708117
[TBL] [Abstract][Full Text] [Related]
4. Towards selective phosphodiesterase 2A (PDE2A) inhibitors: a patent review (2010 - present).
Trabanco AA; Buijnsters P; Rombouts FJ
Expert Opin Ther Pat; 2016 Aug; 26(8):933-46. PubMed ID: 27321640
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants for inhibitor specificity and selectivity in PDE2A using the wheat germ in vitro translation system.
Iffland A; Kohls D; Low S; Luan J; Zhang Y; Kothe M; Cao Q; Kamath AV; Ding YH; Ellenberger T
Biochemistry; 2005 Jun; 44(23):8312-25. PubMed ID: 15938621
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Phosphodiesterase-2A Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay.
Zhang C; Feng LJ; Huang Y; Wu D; Li Z; Zhou Q; Wu Y; Luo HB
J Chem Inf Model; 2017 Feb; 57(2):355-364. PubMed ID: 28055196
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the GAF-B domain from human phosphodiesterase 10A complexed with its ligand, cAMP.
Handa N; Mizohata E; Kishishita S; Toyama M; Morita S; Uchikubo-Kamo T; Akasaka R; Omori K; Kotera J; Terada T; Shirouzu M; Yokoyama S
J Biol Chem; 2008 Jul; 283(28):19657-64. PubMed ID: 18477562
[TBL] [Abstract][Full Text] [Related]
8. Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor.
Helal CJ; Arnold EP; Boyden TL; Chang C; Chappie TA; Fennell KF; Forman MD; Hajos M; Harms JF; Hoffman WE; Humphrey JM; Kang Z; Kleiman RJ; Kormos BL; Lee CW; Lu J; Maklad N; McDowell L; Mente S; O'Connor RE; Pandit J; Piotrowski M; Schmidt AW; Schmidt CJ; Ueno H; Verhoest PR; Yang EX
J Med Chem; 2017 Jul; 60(13):5673-5698. PubMed ID: 28574706
[TBL] [Abstract][Full Text] [Related]
9. Critical amino acids in phosphodiesterase-5 catalytic site that provide for high-affinity interaction with cyclic guanosine monophosphate and inhibitors.
Zoraghi R; Francis SH; Corbin JD
Biochemistry; 2007 Nov; 46(47):13554-63. PubMed ID: 17979301
[TBL] [Abstract][Full Text] [Related]
10. A novel PDE2A reporter cell line: characterization of the cellular activity of PDE inhibitors.
Wunder F; Gnoth MJ; Geerts A; Barufe D
Mol Pharm; 2009; 6(1):326-36. PubMed ID: 19049345
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus.
Fernández-Fernández D; Rosenbrock H; Kroker KS
Synapse; 2015 Oct; 69(10):484-96. PubMed ID: 26178667
[TBL] [Abstract][Full Text] [Related]
12. Binding of cyclic nucleotides to phosphodiesterase 10A and 11A GAF domains does not stimulate catalytic activity.
Matthiesen K; Nielsen J
Biochem J; 2009 Oct; 423(3):401-9. PubMed ID: 19689430
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase 2A localized in the spinal cord contributes to inflammatory pain processing.
Kallenborn-Gerhardt W; Lu R; Bothe A; Thomas D; Schlaudraff J; Lorenz JE; Lippold N; Real CI; Ferreirós N; Geisslinger G; Del Turco D; Schmidtko A
Anesthesiology; 2014 Aug; 121(2):372-82. PubMed ID: 24758774
[TBL] [Abstract][Full Text] [Related]
14. Phosphodiesterase 2A forms a complex with the co-chaperone XAP2 and regulates nuclear translocation of the aryl hydrocarbon receptor.
de Oliveira SK; Hoffmeister M; Gambaryan S; Müller-Esterl W; Guimaraes JA; Smolenski AP
J Biol Chem; 2007 May; 282(18):13656-63. PubMed ID: 17329248
[TBL] [Abstract][Full Text] [Related]
15. A substrate selectivity and inhibitor design lesson from the PDE10-cAMP crystal structure: a computational study.
Lau JK; Li XB; Cheng YK
J Phys Chem B; 2010 Apr; 114(15):5154-60. PubMed ID: 20349929
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.
John A; Sivashanmugam M; Umashankar V; Natarajan SK
J Biomol Struct Dyn; 2017 Aug; 35(10):2155-2168. PubMed ID: 27373313
[TBL] [Abstract][Full Text] [Related]
17. Tumour growth inhibition and anti-angiogenic effects using curcumin correspond to combined PDE2 and PDE4 inhibition.
Abusnina A; Keravis T; Zhou Q; Justiniano H; Lobstein A; Lugnier C
Thromb Haemost; 2015 Feb; 113(2):319-28. PubMed ID: 25230992
[TBL] [Abstract][Full Text] [Related]
18. Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders.
Mikami S; Sasaki S; Asano Y; Ujikawa O; Fukumoto S; Nakashima K; Oki H; Kamiguchi N; Imada H; Iwashita H; Taniguchi T
J Med Chem; 2017 Sep; 60(18):7658-7676. PubMed ID: 28759228
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase-2 inhibitor reverses post-traumatic stress induced fear memory deficits and behavioral changes via cAMP/cGMP pathway.
Chen L; Liu K; Wang Y; Liu N; Yao M; Hu J; Wang G; Sun Y; Pan J
Eur J Pharmacol; 2021 Jan; 891():173768. PubMed ID: 33271150
[TBL] [Abstract][Full Text] [Related]
20. [1,2,4]Triazolo[1,5-
Tresadern G; Velter I; Trabanco AA; Van den Keybus F; Macdonald GJ; Somers MVF; Vanhoof G; Leonard PM; Lamers MBAC; Van Roosbroeck YEM; Buijnsters PJJA
J Med Chem; 2020 Nov; 63(21):12887-12910. PubMed ID: 33105987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
